30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Hassard James

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hassard James's trades of Crinetics Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-09 2024-07-05
PlS Planned sale
36,104 -33.3%
400.22
US$4,585,112 		36,104 -33.3% 400.22 US$4,585,112
2024-07-05 2024-07-05
PrS Proposed sale
77,348
443.68
US$4,145,560 		77,348 443.68 US$4,145,560
2024-06-24 2024-06-21
PlS Planned sale
55,626 -38.1%
371.91
US$2,965,254 		55,626 -38.1% 371.91 US$2,965,254
2024-06-21 2024-06-21
PrS Proposed sale
15,000
44.66
US$669,934 		15,000 44.66 US$669,934
2021-06-24 2021-06-22
S Sale
3,625 -3.3%
89.22
US$323,422 		3,625 -3.3% 89.22 US$323,422
2021-01-08 2021-01-07
PlS Planned sale
15,625 -12.5%
75.00
US$1,171,875 		15,625 -12.5% 75.00 US$1,171,875